Electromed, Inc.

Electromed, Inc. (NYSE American: ELMD) develops, manufactures, markets and sells airway-clearance medical devices for people with impaired pulmonary function. Its principal product, the SmartVest Airway Clearance System, delivers high-frequency chest wall oscillation therapy using a programmable generator and wearable garment to help clear mucus and secretions. The system is prescribed for conditions including bronchiectasis, cystic fibrosis and neuromuscular diseases, and is sold for homecare and hospital use. Models include SmartVest SQL and SmartVest Clearway; acute-care products include the single-patient-use SmartVest and SmartVest Wrap. Electromed primarily uses a direct-to-patient and provider model, obtaining clinician referrals, helping patients navigate insurance claims, and delivering and training patients to use devices at home. Hospitals and a limited number of home medical equipment distributors are also customers, while international sales are primarily through independent distributors. The company operates as one business and recorded $73.4 million in U.S. revenue in fiscal 2026; 95.3% of that amount came from homecare sales and 4.7% from hospitals.